By LabPulse.com staff writers

August 28, 2019 -- Performing hemoglobin A1c (HbA1c) testing four times a year reduces costs and improves quality of life for individuals with diabetes compared to less frequent testing, according to a study conducted by Primary PartnerCare, a physician network in New York.

Diabetes affects more than 30 million people in the U.S. each year, at an estimated cost of $327 billion in 2017, including $237 billion in direct medical costs. Compared to those without the condition, people with diabetes have two to three times the average amount of medical expenses, according to Primary PartnerCare.

The American Diabetes Association (ADA) recommends hemoglobin A1c testing four times per year, but many primary care physicians scale this back to two times a year if the patient has a "normal" HbA1c test. Primary PartnerCare decided to study patients within its accountable care organization to see how the ADA's guidelines affected physician practice.

The study findings showed a direct correlation between the frequency of HbA1c testing and healthcare costs. The fewer the tests, the higher the hospital admission costs, with those who were tested four times annually incurring costs 43% lower than those who were never tested.

Hospital admission costs based on No. of HbA1c tests
  No. of tests
0 1 2 3 4
Hospital admission costs per patient $4,103.32 $3,281.67 $2,870.98 $2,762.31 $2,358.37

Given the low cost of HbA1c testing -- an average of $11.75 per test -- increasing the frequency of testing is a no-brainer, according to Dr. Harry Jacob, chief medical officer of Primary PartnerCare.

"Increasing the frequency of [hemoglobin] A1c testing for our patients is an obvious win," he said.

Blood sugar test from GE's Drawbridge clears FDA
Drawbridge Health, a privately held company founded by GE, announced that its OneDraw single-use point-of-care device for testing hemoglobin A1c in people...
What's new for testing in diabetes prevention guideline
The U.S. Endocrine Society's updated practice guideline for preventing heart disease and type 2 diabetes, published online on July 31, clarifies current...
Random blood glucose tests poised for diabetes screening
A retrospective study of almost 1 million U.S. veterans shows the potential for population-wide random plasma glucose testing for large-scale screening,...
Abbott launches rapid point-of-care blood glucose test
Abbott has launched its Afinion hemoglobin A1c Dx test for use in diagnosing diabetes and monitoring blood glucose in point-of-care settings.
Siemens builds on diabetes testing
Siemens Healthineers has released a hemoglobin A1c test that it believes will help clinicians diagnose and monitor patients with diabetes evaluated with...

Copyright © 2019 LabPulse.com

Last Updated np 8/27/2019 4:31:10 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email